$315.00
2.26% yesterday
NYSE, Dec 10, 10:00 pm CET

Bio-Rad Laboratories, Inc. Class B Stock price

$315.00
+7.62 2.48% 1M
+84.48 36.65% 6M
-13.51 4.11% YTD
-24.87 7.32% 1Y
-103.28 24.69% 3Y
-239.78 43.22% 5Y
+177.99 129.91% 10Y
+253.50 412.20% 20Y
NYSE, Closing price Wed, Dec 10 2025
+6.95 2.26%

Key metrics

Basic
Market capitalization
$8.5b
Enterprise Value
$8.3b
Net debt
positive
Cash
$1.4b
Shares outstanding
27.0m
Valuation (TTM | estimate)
P/E
negative | 31.2
P/S
3.3 | 3.3
EV/Sales
3.2 | 3.2
EV/FCF
24.6
P/B
1.3
Financial Health
Equity Ratio
70.2%
Return on Equity
-28.1%
ROCE
2.9%
ROIC
2.6%
Debt/Equity
0.2
Financials (TTM | estimate)
Revenue
$2.6b | $2.6b
EBITDA
- | $456.0m
EBIT
$262.5m | $307.5m
Net Income
$-675.9m | $272.7m
Free Cash Flow
$336.7m
Growth (TTM | estimate)
Revenue
-0.9% | 1.8%
EBITDA
- | 51.1%
EBIT
-23.5% | 3.0%
Net Income
13.2% | 114.8%
Free Cash Flow
50.5%
Margin (TTM | estimate)
Gross
52.4%
EBITDA
- | 17.5%
EBIT
10.3%
Net
-26.4% | 10.4%
Free Cash Flow
13.2%
More
EPS
$-25.1
FCF per Share
$12.5
Short interest
5.1%
Employees
8k
Rev per Employee
$330.0k
Show more

Is Bio-Rad Laboratories, Inc. Class B a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,085 stocks worldwide.

Bio-Rad Laboratories, Inc. Class B Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Bio-Rad Laboratories, Inc. Class B forecast:

6x Buy
60%
4x Hold
40%

Analyst Opinions

10 Analysts have issued a Bio-Rad Laboratories, Inc. Class B forecast:

Buy
60%
Hold
40%

Financial data from Bio-Rad Laboratories, Inc. Class B

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
2,557 2,557
1% 1%
100%
- Direct Costs 1,217 1,217
3% 3%
48%
1,341 1,341
5% 5%
52%
- Selling and Administrative Expenses 807 807
1% 1%
32%
- Research and Development Expense 271 271
9% 9%
11%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 263 263
23% 23%
10%
Net Profit -676 -676
13% 13%
-26%

In millions USD.

Don't miss a Thing! We will send you all news about Bio-Rad Laboratories, Inc. Class B directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Bio-Rad Laboratories, Inc. Class B Stock News

Neutral
The Motley Fool
about one month ago
The market didn't react positively to the diagnostics specialist's third-quarter earnings report. It beat on both the top and bottom lines, but growth rates were low.
Neutral
Seeking Alpha
about one month ago
Bio-Rad Laboratories, Inc. ( BIO ) Q3 2025 Earnings Call October 29, 2025 5:00 PM EDT Company Participants Yong Chung - Vice President of Investor Relations Jonathan DiVincenzo - President & COO Roop Lakkaraju - Executive VP & CFO Norman Schwartz - Chairman & CEO Conference Call Participants Patrick Donnelly - Citigroup Inc., Research Division Daniel Leonard - UBS Investment Bank, Research Divi...
Neutral
Business Wire
about one month ago
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the third quarter ended September 30, 2025. “During the third quarter, we continued to navigate a dynamic global environment and evolving conditions across the markets for our life science and clini...
More Bio-Rad Laboratories, Inc. Class B News

Company Profile

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Sciences and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Head office United States
CEO Norman Schwartz
Employees 7,700
Founded 1952
Website www.bio-rad.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today